Kurmi, Kiran <br/><br/>
Tyrosine Phosphorylation of Mitochondrial Creatine Kinase 1 Enhances a Druggable Tumor Energy Shuttle Pathway.  [electronic resource] 

 -  Cell metabolism  12 2018 
 - 833-847.e8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-7420 
<br/><br/><label>Standard No.: </label>10.1016/j.cmet.2018.08.008  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Breast Neoplasms--metabolism<br/>Cell Line, Tumor<br/>Cell Transformation, Neoplastic<br/>Creatine Kinase--genetics<br/>Creatinine--analogs & derivatives<br/>Drug Resistance, Neoplasm<br/>Energy Metabolism<br/>Energy Transfer<br/>Female<br/>Gene Knockdown Techniques<br/>Humans<br/>Lapatinib--therapeutic use<br/>Mice<br/>Mice, Nude<br/>Mitochondria--metabolism<br/>Mitochondrial Proteins--metabolism<br/>Phosphocreatine--metabolism<br/>Phosphorylation<br/>Receptor, ErbB-2--metabolism<br/>Trastuzumab--therapeutic use<br/>Xenograft Model Antitumor Assays